David Piñeyro - Concepedia

Author

David Piñeyro

Institució Catalana de Recerca i Estudis Avançats ORCID

Also Known As

D. Pineyro, David Piñeyro, Piñeyro, David

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Institució Catalana de Recerca i Estudis Avançats Centro de Investigación Biomédica en Red de Cáncer Universitat de Barcelona Josep Carreras Leukaemia Research Institute Institut d'Investigació Biomédica de Bellvitge

About

David Piñeyro is an author at Institució Catalana de Recerca i Estudis Avançats specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	657
2	Cell Biology	7	7	320
3	Natural Sciences	4	4	188
4	Engineering	2	2	49
5	Biology	1	1	13

David Piñeyro

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes, The Lancet Respiratory Medicine Anti-pd-1 TreatmentMedicineRetrospective AnalysisCancer GenomicsBronchial Neoplasm	2018	214
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program Maxime Janin, Vanessa Ortiz-Barahona, Manuel Castro de Moura, Acta Neuropathologica	2019	191
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, Journal of Hepatology	2020	138
Inosine modifications in human tRNAs are incorporated at the precursor tRNA level Adrián Gabriel Torres, David Piñeyro, Marta Rodríguez-Escribà, Nucleic Acids Research Human TrnasGeneticsMolecular BiologyProtein SynthesisLong Non-coding Rna	2015	133
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment David A. Wheeler, Naoko Takebe, Toshinori Hinoue, Cancer Cell MedicinePathologyCancer GenomicsMolecular FeaturesOncology	2020	98
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer Laia Piqué, Alexia Martínez de Paz, David Piñeyro, Oncogene Rna-binding Protein Celf2Rna ProcessingMedicineEpigenetic InactivationEpigenetic Change	2019	83
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition Cristina Oliveira-Mateos, Anaís Sánchez‐Castillo, Marta Soler, Nature Communications	2019	60
Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer Margalida Rosselló-Tortella, Pere Llinàs‐Arias, Yuriko Sakaguchi, Proceedings of the National Academy of Sciences	2020	56
The DNA methylation landscape of human cancer organoids available at the American type culture collection Ricky S. Joshi, Manuel Castro de Moura, David Piñeyro, Epigenetics EngineeringEpigenetic ChangeGeneticsDna MethylationDna Analysis	2020	35
Genetically predicted telomere length and Alzheimer’s disease endophenotypes: a Mendelian randomization study Blanca Rodríguez‐Fernández, Natàlia Vilor‐Tejedor, Eider M. Arenaza‐Urquijo, Alzheimer s Research & Therapy	2022	33

Page 1